Arcutis Biotherapeutics Inc (ARQT)
8.60
-0.23
(-2.60%)
USD |
NASDAQ |
May 02, 16:00
8.60
0.00 (0.00%)
After-Hours: 19:22
Arcutis Biotherapeutics Free Cash Flow (Quarterly): -56.25M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -56.25M |
September 30, 2023 | -44.05M |
June 30, 2023 | -66.76M |
March 31, 2023 | -80.43M |
December 31, 2022 | -71.19M |
September 30, 2022 | -90.65M |
June 30, 2022 | -62.06M |
March 31, 2022 | -57.10M |
December 31, 2021 | -51.97M |
September 30, 2021 | -41.02M |
Date | Value |
---|---|
June 30, 2021 | -35.87M |
March 31, 2021 | -46.76M |
December 31, 2020 | -32.72M |
September 30, 2020 | -33.80M |
June 30, 2020 | -25.78M |
March 31, 2020 | -21.05M |
December 31, 2019 | -16.86M |
September 30, 2019 | -10.73M |
June 30, 2019 | -8.285M |
March 31, 2019 | -7.257M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-90.65M
Minimum
Sep 2022
-8.285M
Maximum
Jun 2019
-44.91M
Average
-44.05M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
AdaptHealth Corp | 66.62M |
Puma Biotechnology Inc | 10.41M |
Adverum Biotechnologies Inc | -21.52M |
Apellis Pharmaceuticals Inc | -97.97M |
Karuna Therapeutics Inc (DELISTED) | -111.86M |